Abstract
Controlling blood pressure (BP) for patients with stage 2 hypertension remains challenging. This research aimed to: (i) identify predictors of failure to achieve BP control, (ii) determine the association of adding one additional antihypertensive class with achieving BP control, and (iii) describe the prescribed antihypertensive regimens. Electronic medical record data from 25 multi-specialty medical groups in the USA were used. The study cohort included patients with stage 2 hypertension in 2012. BP control rates were determined at 6 months from the date of the stage 2 BP. Using multivariable logistic regression and validation by Monte Carlo simulation, we determined independent baseline predictors of not achieving BP control (<140/90). Included were 107 903 patients. Baseline predictors of failure to achieve BP control included the following: a prior stage 2 BP, systolic BP ≥ 165, Black race, male sex, income ≤ $35 000, body mass index ≥ 30, age ≥ 65 years, and no office visits. Increasing from single-class to dual-class antihypertensive therapy was associated with a 42% increased odds of achieving BP control (odds ratio 1.42; 95% CI 1.22, 1.64); however, this effect was attenuated as the number of baseline antihypertensive c...Continue Reading
References
Dec 4, 2002·The Journal of Clinical Hypertension·William C CushmanUNKNOWN ALLHAT Collaborative Research Group
Dec 21, 2002·Lancet·Sarah LewingtonUNKNOWN Prospective Studies Collaboration
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Nov 5, 2003·Annals of Internal Medicine·Roberto Pastor-BarriusoEliseo Guallar
Feb 26, 2004·Hypertension·Luis A Vara-Gonzalez, Pedro Munoz Cacho
Apr 27, 2005·Archives of Internal Medicine·Chi-yuan HsuCarlos Iribarren
Jan 10, 2008·The Annals of Pharmacotherapy·Derek WeyckerGerry Oster
May 26, 2010·Hypertension·Alexander TurchinPaul R Conlin
May 27, 2010·JAMA : the Journal of the American Medical Association·Brent M EganR Neal Axon
Sep 29, 2011·Archives of Internal Medicine·Fritha MorrisonAlexander Turchin
May 9, 2012·Hypertension·Brent M EganKristina S Yu-Isenberg
Apr 12, 2013·PloS One·Casey OlivesStephen S Lim
Jul 3, 2013·Journal of Hypertension·Giuseppe ManciaUNKNOWN Task Force Members
Jun 3, 2014·Lancet·Eleni RapsomanikiHarry Hemingway
Jun 28, 2014·The Canadian Journal of Cardiology·Jessica GorguiStella S Daskalopoulou
Aug 12, 2014·Journal of the American College of Cardiology·John J SimSteven J Jacobsen
Aug 30, 2014·Pharmacoepidemiology and Drug Safety·Christopher G RowanJeffrey A Spaeder
Sep 23, 2014·The Journal of Clinical Hypertension·Reinhold KreutzAlejandro de la Sierra
Citations
Dec 24, 2016·International Journal of Environmental Research and Public Health·Da FengLiang Zhang
Oct 17, 2018·PloS One·E VoneshJ S Rumsfeld
Jan 11, 2019·PloS One·Rachel CoyleSimon de Lusignan
Jun 28, 2021·Healthcare : the Journal of Delivery Science and Innovation·Kelly H BurkittLeslie R M Hausmann
Aug 12, 2021·Journal of General Internal Medicine·Kevin FiscellaJonathan N Tobin